Page 2 of Novo Nordisk

Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their purpose is to address…

Trump’s tariff threat: Experts have warned that additional levies will only serve to push up prices in the already costly…

The company predicted operating profit for 2025 to climb between 19% and 27%, compared to growth of 26% last year.

Novo expects to file for a label expansion for Rybelsus in the United States and the European Union around the…

Existing obesity drugs like Wegovy and Eli Lilly’s Zepbound are injectable. Pills require larger amounts of active ingredients, which makes…

As per the latest Indian Council of Medical Research–India Diabetes (ICMR-INDIAB) study, the prevalence of diabetes and other metabolic non-communicable…

The application for approval by Jiuyuan Gene Engineering comes amid surging demand for semaglutide that far outpaces supply globally.

European drug regulators last year announced an investigation after receiving reports of suicidal thoughts from patients taking GLP-1 drugs, including…

The World Anti-Doping Agency has also banned the substance, which it says hasn’t been sufficiently studied.

As investors bet that this new class of weight-loss drugs will improve the overall health of millions of Americans, US…